Abstract
Objective: A “frameless” intrauterine drug delivery system that releases 14 μg/d of levonorgestrel was used to treat nonatypical and atypical endometrial hyperplasia in 12 women. Study Design: This noncomparative study had up to 3 to 4 years of follow-up. Results: The cure rate was 100%, as confirmed by repeat endometrial biopsy. Conclusion: This method could be considered an alternative to hysterectomy. (Am J Obstet Gynecol 2003;188:1297-8.)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
